Patents by Inventor Julien KORAC

Julien KORAC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS
    Publication number: 20250002475
    Abstract: Compounds of formula (I), or the pharmaceutically acceptable salts and/or the solvates thereof, wherein m, n, R1, R2, R3, R4, R5, L, Ar1 and Ar2 are as defined as disclosed, which are useful as inhibitors of METTL3 (N6-adenosine-methlytransferase subunit) activity, in particular for the treatment of proliferative diseases such as cancers.
    Type: Application
    Filed: July 25, 2024
    Publication date: January 2, 2025
    Applicant: EPICS THERAPEUTICS
    Inventors: Guillaume DUTHEUIL, Graeme FRASER, Catherine SORLET, Killian OUKOLOFF, François LENOIR, Julien KORAC
  • Piperidine derivatives as METTL3 inhibitors
    Patent number: 12091400
    Abstract: Compounds of formula (I), or the pharmaceutically acceptable salts and/or the solvates thereof, wherein m, n, R1, R2, R3, R4, R5, L, Ar1 and Ar2 are as defined as disclosed, which are useful as inhibitors of METTL3 (N6-adenosine-methlytransferase subunit) activity, in particular for the treatment of proliferative diseases such as cancers.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: September 17, 2024
    Assignee: EPICS THERAPEUTICS
    Inventors: Guillaume Dutheuil, Graeme Fraser, Catherine Sorlet, Killian Oukoloff, François Lenoir, Julien Korac
  • PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS
    Publication number: 20240270716
    Abstract: Compounds of formula (I), or the pharmaceutically acceptable salts and/or the solvates thereof, wherein m, n, R1, R2, R3, R4, R5, L, Ar1 and Ar2 are as defined as disclosed, which are useful as inhibitors of METTL3 (N6-adenosine-methlytransferase subunit) activity, in particular for the treatment of proliferative diseases such as cancers.
    Type: Application
    Filed: January 19, 2024
    Publication date: August 15, 2024
    Applicant: EPICS THERAPEUTICS
    Inventors: Guillaume DUTHEUIL, Graeme FRASER, Catherine SORLET, Killian OUKOLOFF, François LENOIR, Julien KORAC